FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

422264003: Powder for prolonged-release suspension for injection (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2614906013 Powder for injectable extended release suspension (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2617533011 Powder for injectable extended release suspension en Synonym Inactive Entire term case insensitive SNOMED CT core module
2660523019 Powder for injectable extended release suspension (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3620912013 Powder for prolonged-release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620913015 Powder for prolonged-release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3620914014 Powder for extended-release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for prolonged-release suspension for injection Is a Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form administration method Inject true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form transformation Disperse true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has basic dose form Powder true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lyophilized powder for prolonged-release suspension for injection Is a True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 25 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 50 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely exenatide 2 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 300 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start